Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance
Financial Results and Introduces 2025 Full-Year Guidance ST. PAUL, Minn., Feb. 27, 2025 -- Reported sales increased 1.9% to $2.074 billion; organic sales increased 2.3% -- GAAP diluted Earnings Per Share (EPS) of $0.
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...
Sees 21-25 system replacements in FY25.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ratings ...
Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...
Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying The Dow Jones closed higher by around 75 points on Friday. When insiders purchase or sell shares, it indicates their confidence or ...
The life sciences technology company posted a loss of $0.22 per share for Q4, $0.01 worse than the analyst estimate of -$0.21. Revenue came in at $8.2 million, beating the consensus estimate of $7.8 ...
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect Rapid Micro Biosystems to post ...
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback